Search Results

There are 7311 results for: content related to: Dropout in the Treatment of Erectile Dysfunction with PDE5: A Study on Predictors and a Qualitative Analysis of Reasons for Discontinuation

  1. You have free access to this content
    Molecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health

    Journal of Andrology

    Volume 29, Issue 1, January-February 2008, Pages: 3–14, Arthur L. Burnett

    Version of Record online : 2 JAN 2013, DOI: 10.2164/jandrol.107.003483

  2. You have full text access to this OnlineOpen article
    Adherence to Phosphodiesterase Type 5 Inhibitors in the Treatment of Erectile Dysfunction in Long-Term Users: How Do Men Use the Inhibitors?

    Sexual Medicine

    Volume 2, Issue 2, June 2014, Pages: 96–102, Ana Carvalheira, Vera Forjaz and Nuno Monteiro Pereira

    Version of Record online : 27 MAY 2014, DOI: 10.1002/sm2.31

  3. Phosphodiesterase Inhibitors: A Chemogenomic View

    Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective

    Martin Hendrix, Christopher Kallus, Pages: 243–288, 2005

    Published Online : 12 JUL 2005, DOI: 10.1002/3527603948.ch9

  4. Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit

    The Prostate

    Volume 73, Issue 4, March 2013, Pages: 428–441, Annamaria Morelli, Paolo Comeglio, Sandra Filippi, Erica Sarchielli, Linda Vignozzi, Elena Maneschi, Ilaria Cellai, Mauro Gacci, Andrea Lenzi, Gabriella B. Vannelli and Mario Maggi

    Version of Record online : 19 SEP 2012, DOI: 10.1002/pros.22584

  5. You have free access to this content
    Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure

    British Journal of Pharmacology

    Volume 170, Issue 7, December 2013, Pages: 1396–1409, Wei Gong, Quanlu Duan, Zhejun Cai, Chen Chen, Li Ni, Mengwen Yan, Xingxu Wang, Katherine Cianflone and Dao Wen Wang

    Version of Record online : 14 NOV 2013, DOI: 10.1111/bph.12346

  6. Combination of Psychological Intervention and Phosphodiesterase-5 Inhibitors for Erectile Dysfunction: A Narrative Review and Meta-Analysis

    The Journal of Sexual Medicine

    Volume 11, Issue 6, June 2014, Pages: 1376–1391, Hannah M. Schmidt, Thomas Munder, Heike Gerger, Sarah Frühauf and Jürgen Barth

    Version of Record online : 19 MAR 2014, DOI: 10.1111/jsm.12520

  7. Platelet-Derived Growth Factor Regulation of Type-5 Phosphodiesterase in Human and Rat Penile Smooth Muscle Cells

    The Journal of Sexual Medicine

    Volume 11, Issue 7, July 2014, Pages: 1675–1684, Eleonora Carosa, Alessandra Castri, Chiara Forcella, Guido Sebastiani, Stefania Di Sante, Giovanni L. Gravina, Piero Ronchi, Valeriana Cesarini, Susanna Dolci, Savino Di Stasi, Andrea Lenzi and Emmanuele A. Jannini

    Version of Record online : 19 MAY 2014, DOI: 10.1111/jsm.12568

  8. You have free access to this content
    Allosteric sites of phosphodiesterase-5 (PDE5)

    European Journal of Biochemistry

    Volume 268, Issue 11, June 2001, Pages: 3304–3312, Venkatesh K. Gopal, Sharron H. Francis and Jackie D. Corbin

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1432-1327.2001.02233.x

  9. Beyond Erectile Dysfunction: Understanding PDE5 Activity In The Central Nervous System

    Cyclic-Nucleotide Phosphodiesterases In The Central Nervous System: From Biology to Drug Discovery

    Eva P.P. Bollen, Kris Rutten, Olga A.H. Reneerkens, Harry W.M. Steinbusch, Jos Prickaerts, Pages: 223–246, 2014

    Published Online : 7 MAR 2014, DOI: 10.1002/9781118836507.ch09

  10. Testosterone/Estradiol Ratio Regulates NO-Induced Bladder Relaxation and Responsiveness to PDE5 Inhibitors

    The Journal of Sexual Medicine

    Volume 9, Issue 12, December 2012, Pages: 3028–3040, Linda Vignozzi, Sandra Filippi, Annamaria Morelli, Paolo Comeglio, Ilaria Cellai, Erica Sarchielli, Elena Maneschi, Rosa Mancina, Mauro Gacci, Gabriella Barbara Vannelli and Mario Maggi

    Version of Record online : 11 OCT 2012, DOI: 10.1111/j.1743-6109.2012.02946.x

  11. Optimizing treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction: Opening windows to enhanced sexual function and overall health

    Journal of the American Academy of Nurse Practitioners

    Volume 23, Issue 6, June 2011, Pages: 320–330, Richard Sadovsky, Gerald B. Brock, Mikel Gray, Penny Kaye Jensen, Stephen W. Gutkin and Sebastian Sorsaburu

    Version of Record online : 27 JAN 2011, DOI: 10.1111/j.1745-7599.2010.00590.x

  12. Phosphodiesterase 5 (PDE 5) inhibitors for the treatment of male erectile disorder: Attaining selectivity versus PDE6

    Medicinal Research Reviews

    Volume 26, Issue 3, May 2006, Pages: 369–395, Dmitri Pissarnitski

    Version of Record online : 30 DEC 2005, DOI: 10.1002/med.20053

  13. You have free access to this content
    Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments

    British Journal of Pharmacology

    Volume 165, Issue 5, March 2012, Pages: 1288–1305, Thérèse Keravis and Claire Lugnier

    Version of Record online : 10 FEB 2012, DOI: 10.1111/j.1476-5381.2011.01729.x

  14. Does Current Scientific and Clinical Evidence Support the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Premature Ejaculation? A Systematic Review and Meta-analysis

    The Journal of Sexual Medicine

    Volume 9, Issue 9, September 2012, Pages: 2404–2416, Anastasios D. Asimakopoulos, Roberto Miano, Enrico Finazzi Agrò, Giuseppe Vespasiani and Enrico Spera

    Version of Record online : 16 JAN 2012, DOI: 10.1111/j.1743-6109.2011.02628.x

  15. EFFECT OF THE PHOSPHODIESTERASE 5 INHIBITORS SILDENAFIL, TADALAFIL AND VARDENAFIL ON RAT ANOCOCCYGEUS MUSCLE: FUNCTIONAL AND BIOCHEMICAL ASPECTS

    Clinical and Experimental Pharmacology and Physiology

    Volume 36, Issue 4, April 2009, Pages: 358–366, Haroldo A Toque, Fernanda BM Priviero, Saiprasad M Zemse, Edson Antunes, Cleber E Teixeira and R Clinton Webb

    Version of Record online : 17 OCT 2008, DOI: 10.1111/j.1440-1681.2008.05071.x

  16. Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation

    The Journal of Sexual Medicine

    Volume 12, Issue 9, September 2015, Pages: 1878–1885, Nikolai A. Sopko, Hotaka Matsui, Johanna L. Hannan, Dan Berkowitz, Hunter C. Champion, Lewis L. Hsu, Biljana Musicki, Arthur L. Burnett and Trinity J. Bivalacqua

    Version of Record online : 7 SEP 2015, DOI: 10.1111/jsm.12976

  17. HIGHLIGHTED POSTER TOURS

    The Journal of Sexual Medicine

    Volume 9, Issue s5, December 2012, Pages: 336–356,

    Version of Record online : 3 DEC 2012, DOI: 10.1111/jsm.12007_2

  18. UNMODERATED POSTER PRESENTATION ABSTRACTS

    The Journal of Sexual Medicine

    Volume 3, Issue s3, March 2006, Pages: 224–286,

    Version of Record online : 24 FEB 2006, DOI: 10.1111/j.1743-6109.2006.00188_4.x

  19. Effect of Chronic Administration of PDE5 Combined with Glycemic Control on Erectile Function in Streptozotocin-Induced Diabetic Rats

    The Journal of Sexual Medicine

    Volume 12, Issue 3, March 2015, Pages: 600–610, Woo Suk Choi, Oh Seong Kwon, Sung Yong Cho, Jae-Seung Paick and Soo Woong Kim

    Version of Record online : 20 NOV 2014, DOI: 10.1111/jsm.12752

  20. Treating Erectile Dysfunction and Central Neurological Diseases with Oral Phosphodiesterase Type 5 Inhibitors. Review of the Literature

    The Journal of Sexual Medicine

    Volume 9, Issue 4, April 2012, Pages: 970–985, Giuseppe Lombardi, Federico Nelli, Maria Celso, Marco Mencarini and Giulio Del Popolo

    Version of Record online : 3 FEB 2012, DOI: 10.1111/j.1743-6109.2011.02615.x